Uveitis due to bisphosphonates: A rare side effect?;Uveítis por bisfosfonatos: ¿un raro efecto secundario?

Reumatologia Clinica

Volumn 12, Issue 2, 2016, Pages 119-

  Martín Guillén, Sonia ^a   Hurtado García, Robert ^a   Álvarez Cienfuegos, Antonio ^a  

^a HOSPITAL VEGA BAJA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ADVERSE OUTCOME; HUMAN; LETTER; UVEITIS; CASE REPORT; CHEMICALLY INDUCED; FEMALE; MIDDLE AGED;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; MIDDLE AGED; UVEITIS;

EID: 84930886684     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2015.04.006     Document Type: Letter

References (5)

1. French D., Margo C. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina. 2008, 28:889-893.
2. Vidal M.A., Medina C., Torres L.M. Seguridad de los bisfosfonatos. Rev Soc Esp Dolor. 2011, 18:43-55.
3. Etminan M., Forooghian F., Maberley D. Inflammatory ocular adverse events with the use of oral bisphosphonates: A retrospective cohort study. CMAJ. 2012, 184:E431-E434.
4. Ghose K., Waterworth R., Trolove P., Highton J. Uveitis associated with pamidronate. Aust NZ J Med. 1994, 24:320.
5. Cano Parra J., Díaz Llopis M. Drug induced uveitis. Arch Soc Esp Oftalmol. 2005, 80:137-149.